Evommune (EVMN) Other Working Capital Changes (2024 - 2026)
Evommune (EVMN) posted quarterly Other Working Capital Changes of -$193000.0 for Q1 2026, up 6.31% year-over-year from -$181543.4 in Q1 2025, and up 91.99% quarter-over-quarter from -$2.4 million in Q4 2025.
Evommune (EVMN) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported Other Working Capital Changes for 3 consecutive years, with -$193000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 6.31% year-over-year to -$193000.0; the TTM figure through Mar 2026 stood at -$3.0 million (changed N/A YoY), while the FY2025 annual figure was -$3.0 million, down 290.12% from the prior year.
- Other Working Capital Changes climbed to -$193000.0 in Q1 2026 per EVMN's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.0 million in Q1 2025 and bottomed at $85000.0 in Q1 2026.
- Historically, Other Working Capital Changes has averaged $1.3 million across 3 years, with a median of $539000.0 in 2024.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes slumped 1092.57% — and 2026, when it increased 6.31%.
- Evommune's Other Working Capital Changes stood at -$202000.0 in 2024, then plunged by 1092.57% to -$2.4 million in 2025, then soared by 91.99% to -$193000.0 in 2026.
- Business Quant data shows EVMN's Other Working Capital Changes at -$193000.0 in Q1 2026, -$2.4 million in Q4 2025, and -$206000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Evommune | 531.53 Mn | 330.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -943,000.00 |
| Jun 30, 2026 | -943,000.00 |
| Jun 30, 2026 | -943,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Dec 31, 2025 | 372,000.00 |
| Mar 31, 2025 | 3.96 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 706,000.00 |
| Dec 31, 2024 | 706,000.00 |
| Dec 31, 2024 | 706,000.00 |